Jin Yang Pharmaceutical Co. Ltd (007370) — Capital Reinvestment Ratio

Latest as of September 2025: 1.09x

Jin Yang Pharmaceutical Co. Ltd (007370) has a Capital Reinvestment Ratio of 1.09x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.64 Billion) in capital expenditures (₩1.79 Billion). See how leveraged is Jin Yang Pharmaceutical Co. Ltd's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.09x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.64 Billion
KRW

Capital Expenditures

₩1.79 Billion
KRW

Data as of

Sep 2025
Most recent filing

Jin Yang Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2018–2025)

This chart tracks Jin Yang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Check Jin Yang Pharmaceutical Co. Ltd (007370) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Jin Yang Pharmaceutical Co. Ltd (2018–2025)

Year-by-year Capital Reinvestment Ratio for Jin Yang Pharmaceutical Co. Ltd from 2018 to 2025. For live market cap and broader valuation context, see Jin Yang Pharmaceutical Co. Ltd market cap and net worth.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 2.51x ₩1.46 Billion ₩3.67 Billion ▲ +3285.2%
2024 0.07x ₩12.79 Billion ₩947.22 Million ▼ -58.8%
2023 0.18x ₩8.53 Billion ₩1.53 Billion ▼ -58.4%
2022 0.43x ₩7.45 Billion ₩3.22 Billion ▼ -66.2%
2021 1.28x ₩1.97 Billion ₩2.52 Billion ▲ +485.0%
2020 0.22x ₩6.24 Billion ₩1.36 Billion ▲ +113.6%
2019 0.10x ₩7.21 Billion ₩736.71 Million ▼ -67.0%
2018 0.31x ₩1.06 Billion ₩327.39 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow